Needham & Company Maintains a 'Buy' on Biolase Technology (BLTI); Q4 Shortfall, But Outlook Strong
Go back to Needham & Company Maintains a 'Buy' on Biolase Technology (BLTI); Q4 Shortfall, But Outlook Strong| Biolase Technology, Inc. (NASDAQ: BLTI) | Delayed: 2.42 +0.06 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.36 | 52 Week High | $6.13 | |||
| Open | $2.36 | 52 Week Low | $2.14 | |||
| Day High | $2.49 | P/E | N/A | |||
| Day Low | $2.36 | EPS | $-0.17 | |||
| Volume | 80,153 | |||||
| Henry Schein, Inc. (NASDAQ: HSIC) | Delayed: 89.77 -0.35 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.12 | 52 Week High | $183.00 | |||
| Open | $90.09 | 52 Week Low | $142.64 | |||
| Day High | $90.67 | P/E | 18.21 | |||
| Day Low | $89.46 | EPS | $4.93 | |||
| Volume | 1,162,494 | |||||
